Reference
1. Scully M, Cataland S, Coppo P, de la Rubia J, Friedman KD, Kremer
Hovinga J, et al. Consensus on the standardization of terminology in
thrombotic thrombocytopenic purpura and related thrombotic
microangiopathies. Journal of thrombosis and haemostasis : JTH.
2017;15(2):312-22.
2. Caltik A, Demircin G, Bülbül M, Erdogan O, Akyüz SG, Arda N. An
unusual case of ANA negative systemic lupus erythematosus presented with
vasculitis, long-standing serositis and full-house nephropathy.
Rheumatology international. 2013;33(1):219-22.
3. Simmons SC, Smith ML, Chang-Miller A, Keddis MT. Antinuclear
Antibody-Negative Lupus Nephritis with Full House Nephropathy: A Case
Report and Review of the Literature. American journal of nephrology.
2015;42(6):451-9.
4. Li QY, Yu F, Zhou FD, Zhao MH. Plasmapheresis Is Associated With
Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic
Microangiopathy: A Case Series Study. Medicine. 2016;95(18):e3595.
5. Sun F, Wang X, Wu W, Wang K, Chen Z, Li T, et al. TMA secondary to
SLE: rituximab improves overall but not renal survival. Clinical
rheumatology. 2018;37(1):213-8.